Your analogy conveys to me that the FDA approves a drug produced by a singular specific company. The NSA did not go to that extent. However, I don't think you are too off the mark. Nearly all things TPM is Wave's oyster to dominate or squander. Perhaps that why calls for a savvy COO or non-techie CEO are so prevalent.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.